The addition of Colleen Hoke to our executive management team reflects Novum’s ongoing commitment to consistently deliver to our clients regulatory compliance, innovative science and superior customer service.
Pittsburgh, PA (PRWEB) January 17, 2012
In response to clients increasing demand for its Phase I through IV clinical research services, Novum Pharmaceutical Research Services, Inc. today announced the addition of Colleen Hoke as the new Vice President of Business Administration.
With over 20 years of experience in clinical research, from both the provider and contract research services perspective, Colleen Hoke brings a highly responsive and disciplined project management approach coupled with a deep understanding of the clinical trials industry in operations, client management and business development. She joins Novum from Charles River Laboratories, where she was General Manager responsible for Phase I Services. Prior to Charles River, she spent seven years in oncology research providing overall leadership for the business operations, client management and contracting components for a national provider network.
“Our ongoing value is based on delivering highly flexible timelines, well-designed studies in a price competitive manner. As Novum continues to grow, to meet the expanding needs of our global client base, we understand that our service levels will need to continue to exceed client expectations. This new addition to our executive team will help further our partnership with clients and allow us to deliver an enhanced customer experience and related operational activities as well as new services when our clients need them,” said Chris Hendy PhD, President and Chief Executive Officer of Novum. "The addition of Colleen Hoke to our executive management team reflects Novum’s ongoing commitment to consistently deliver to our clients regulatory compliance, innovative science and superior customer service.”
About Novum PRS
Novum is a contract research organization ("CRO") that provides clinical research, data management, statistical and reporting services to the pharmaceutical and related industries. Founded in 1972 it operates Phase I research facilities with a total of 550 beds in three USA locations. Novum’s expanding clinical trials management group, currently focuses on performing Phase II through IV clinical endpoint studies requiring large patient populations in non-serious disease states that are treated in an outpatient setting. Visit http://www.novumprs.com for more information.